ABSTRACT. The effects of acepromazine-butorphanol (AB), midazolam-butorphanol (MB) and medetomidine (Med) on the induction dose of propofol and their compatibility with propofol were evaluated in client-owned dogs. All premedications induced good to excellent sedation and the induction dose of propofol was considerably reduced. Of the tested premedicants, Med induced the deepest sedation and the most potent dose-sparing effect. Induction of anesthesia was excellent to good in all dogs except for one dog premedica ted with MB. Most dogs premedicated with AB or MB showed temporary apnea. Although other adverse effects such as bradycardia or hypotension may also occur, premedication with MB, AB or Med is a valuable technique for the induction of anesthesia with propofol in dogs in a clinical setting. KEY WORDS: canine, premedication, propofol.J. Vet. Med. Sci. 65(10): 1141-1143, 2003 Propofol is an intravenous anesthetic which has highly desirable characteristics such as rapid onset of anesthesia, short duration of action, lack of accumulation upon repeated administration and lack of excitatory effects on induction [1,16]. Because of these beneficial characteristics, propofol is now accepted as a useful agent in dogs. In veterinary anesthesia, preanesthetic medications such as tranquilizers, sedatives and analgesics are commonly used for the safe and smooth induction of anesthesia. The preanesthetic use of drugs has been shown to have a sparing effect on the induction dose of intravenous anesthetics [4,10,11]. Preanesthetic medication has also been reported to modify the cardiovascular effects induced by induction agents. The purpose of this study was to evaluate the effects of acepromazine-butorphanol, midazolam-butorphanol and medetomidine on the dose of propofol needed to induce anesthesia in dogs, and to examine the compatibility of these preanesthetics with propofol in clinical cases.Eighty client-owned dogs were evaluated in this study. These patients were admitted to the Veterinary Medical Center of the University of Tokyo from April of 2000 to July of 2001 for a variety of surgeries or treatments. Their age, body weight, gender, the type of surgery or treatment and the combination of premedicants used before anesthesia are shown in Table 1, which also includes the physical status of each animal before anesthesia based on the American Society of Anesthesiologists (ASA) standards [6,12]. The heart rate (HR) and arterial blood pressure (BP) were monitored non-invasively by a multifunction monitor (Multifunction monitor COLIN BP-58 , Nihon Colin Co. , Tokyo , Japan).The following drugs were used for preanesthetic medication: intramuscular medetomidine (Med; Domitor, Meijiseika Co., Tokyo , Japan) at a dose of 1,000 µg/m 2 , intravenous midazolam (Dormicum , Yamanouchi Pharmaceutical Co., Tokyo , Japan) and butorphanol (Stadol, Bristol -Myers Squibb Co., Tokyo , Japan) (MB) at doses of 0.1 and 0.2 mg/kg, respectively, and intramuscular acepromazine (Prom Ace, Fort Dodge Laboratories Inc., Iowa , U.S.A.) and buto...